Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles

Naturally processed peptides were acid extracted from immunoaffinity- purified HLA-DR2, DR3, DR4, DR7, and DR8. Using the complementary techniques of mass spectrometry and Edman microsequencing, > 200 unique peptide masses were identified from each allele, ranging from 1,200 to 4,000 daltons (10-34 residues in length), and a total of 201 peptide sequences were obtained. These peptides were derived from 66 different source proteins and represented sets nested at both the amino- and carboxy-terminal ends with an average length of 15-18 amino acids. Strikingly, most of the peptides (> 85%) were derived from endogenous proteins that intersect the endocytic/class II pathway, even though class II molecules are thought to function mainly in the presentation of exogenous foreign peptide antigens. The predominant endogenous peptides were derived from major histocompatibility complex-related molecules. A few peptides derived from exogenous bovine serum proteins were also bound to every allele. Four prominent promiscuous self- peptide sets (capable of binding to multiple HLA-DR alleles) as well as 84 allele-specific peptide sets were identified. Binding experiments confirmed that the promiscuous peptides have high affinity for the binding groove of all HLA-DR alleles examined. A potential physiologic role for these endogenous self-peptides as immunomodulators of the cellular immune response is discussed.

[1]  P. Cresswell,et al.  Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers. , 1993, Journal of immunology.

[2]  S. Ceman,et al.  Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. , 1992, Science.

[3]  P. Cresswell,et al.  HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides , 1992, Nature.

[4]  Don C. Wiley,et al.  Atomic structure of a human MHC molecule presenting an influenza virus peptide , 1992, Nature.

[5]  William S. Lane,et al.  Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle , 1992, Nature.

[6]  J. Drijfhout,et al.  Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides. , 1992, Journal of immunology.

[7]  Charles A. Janeway,et al.  Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs , 1992, Nature.

[8]  F. Sinigaglia,et al.  Identification of a motif for HLA-DR1 binding peptides using M13 display libraries , 1992, The Journal of experimental medicine.

[9]  S. Buus,et al.  MHC molecules protect T cell epitopes against proteolytic destruction. , 1992, Journal of immunology.

[10]  J. Sacchettini,et al.  Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Jensen Long-lived complexes between peptide and class II major histocompatibility complex are formed at low pH with no requirement for pH neutralization , 1992, The Journal of experimental medicine.

[12]  William S. Lane,et al.  Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.

[13]  E. Unanue,et al.  Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[14]  P. A. Peterson,et al.  Emerging principles for the recognition of peptide antigens by MHC class I molecules. , 1992, Science.

[15]  A Sette,et al.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.

[16]  Eric O Long,et al.  Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells , 1992, Nature.

[17]  Jim Miller,et al.  Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41 , 1992, Nature.

[18]  Zhuoru Liu,et al.  T cell recognition of self-human histocompatibility leukocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR molecules , 1992, The Journal of experimental medicine.

[19]  H. Grey,et al.  MHC interaction and T cell recognition of carbohydrates and glycopeptides. , 1992, Journal of immunology.

[20]  P. Casey,et al.  Evidence of a role for heterotrimeric GTP-binding proteins in endosome fusion. , 1992, Science.

[21]  M. Anderson,et al.  Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Henderson,et al.  Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. , 1992, Science.

[23]  G. Morahan,et al.  Peripheral T cell tolerance. , 1992, Annual review of immunology.

[24]  S. Pierce,et al.  A case for chaperones in antigen processing. , 1992, Immunology today.

[25]  E. Unanue,et al.  Reduction of disulfide bonds within lysosomes is a key step in antigen processing. , 1991, Journal of immunology.

[26]  A Sette,et al.  Random association between the peptide repertoire of A2.1 class I and several different DR class II molecules. , 1991, Journal of immunology.

[27]  L. Adorini,et al.  Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen. , 1991, Journal of immunology.

[28]  A. Rudensky,et al.  Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.

[29]  C Oseroff,et al.  On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs. , 1991, Journal of immunology.

[30]  D. R. Madden,et al.  Identification of self peptides bound to purified HLA-B27 , 1991, Nature.

[31]  D. R. Madden,et al.  The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation , 1991, Nature.

[32]  R. Germain,et al.  A role for peptide in determining MHC class II structure , 1991, Nature.

[33]  R. Meloen,et al.  HLA polymorphism and T cell recognition of a conserved region of p190, a malaria vaccine candidate. , 1991, International immunology.

[34]  A. Boots,et al.  Antigen processing by endosomal proteases determines which sites of sperm‐whale myoglobin are eventually recognized by T cells , 1991, European journal of immunology.

[35]  Yih-Shyun E. Cheng,et al.  Interferon-induced guanylate-binding proteins lack an N(T)KXD consensus motif and bind GMP in addition to GDP and GTP , 1991, Molecular and cellular biology.

[36]  J. Rothbard,et al.  Conformational and structural characteristics of peptides binding to HLA-DR molecules. , 1991, Journal of immunology.

[37]  H. Rammensee,et al.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.

[38]  S. Schreiber,et al.  Complete amino acid sequence of the FK506 and rapamycin binding protein, FKBP, isolated from calf thymus , 1991, Journal of protein chemistry.

[39]  S. Weiss,et al.  MHC class II—Restricted presentation of intracellular antigen , 1991, Cell.

[40]  H. Geuze,et al.  Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments , 1991, Nature.

[41]  A Sette,et al.  Truncation analysis of several DR binding epitopes. , 1991, Journal of immunology.

[42]  E. Unanue,et al.  Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells , 1991, Cell.

[43]  Y. Kawabe,et al.  Programmed cell death and extrathymic reduction of Vβ8+CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B , 1991, Nature.

[44]  J. Rothbard,et al.  Interactions between immunogenic peptides and MHC proteins. , 1991, Annual review of immunology.

[45]  D. Wiley,et al.  Crystallization of HLA-DR antigens. , 1991, Research in immunology.

[46]  J. Sprent,et al.  Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity , 1990, Cell.

[47]  P. A. Peterson,et al.  Intracellular transport of class II MHC molecules directed by invariant chain , 1990, Nature.

[48]  O. Bakke,et al.  MHC class II-associated invariant chain contains a sorting signal for endosomal compartments , 1990, Cell.

[49]  S. Nathenson,et al.  Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule , 1990, Nature.

[50]  P. A. Peterson,et al.  Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways , 1990, Nature.

[51]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[52]  R W Chesnut,et al.  Characterization of the specificity of peptide binding to four DR haplotypes. , 1990, Journal of immunology.

[53]  Eric O Long,et al.  An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells , 1990, The Journal of experimental medicine.

[54]  P. Parham,et al.  Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule , 1990, The Journal of experimental medicine.

[55]  H. Grey,et al.  The minimal number of class II MHC-antigen complexes needed for T cell activation. , 1990, Science.

[56]  Emil R. Unanue,et al.  Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation , 1990, Nature.

[57]  P. Cresswell,et al.  Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding , 1990, Nature.

[58]  D. Wiley,et al.  Peptide binding to HLA‐DR1: a peptide with most residues substituted to alanine retains MHC binding. , 1990, The EMBO journal.

[59]  J. Rothbard,et al.  Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces. , 1990, International immunology.

[60]  H. Geuze,et al.  The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route , 1990, Cell.

[61]  P. Riska,et al.  The role of the endoplasmic reticulum in antigen processing. N-glycosylation of influenza hemagglutinin abrogates CD4+ cytotoxic T cell recognition of endogenously processed antigen. , 1990, Journal of immunology.

[62]  P. Cresswell,et al.  High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR. , 1990, Journal of immunology.

[63]  R. Klausner,et al.  Class II MHC molecules can use the endogenous pathway of antigen presentation , 1990, Nature.

[64]  Eugene W. Myers,et al.  Basic local alignment search tool. Journal of Molecular Biology , 1990 .

[65]  P Parham,et al.  Structure, function, and diversity of class I major histocompatibility complex molecules. , 1990, Annual review of biochemistry.

[66]  M. A. Saper,et al.  Specificity pockets for the side chains of peptide antigens in HLA-Aw68 , 1990, Nature.

[67]  R. Demars,et al.  Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. , 1989, Journal of immunology.

[68]  D. Anderson,et al.  T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP , 1989, The Journal of experimental medicine.

[69]  L. Eisenlohr,et al.  Class II major histocompatibility complex-restricted T cells specific for a virion structural protein that do not recognize exogenous influenza virus. Evidence that presentation of labile T cell determinants is favored by endogenous antigen synthesis , 1989, The Journal of experimental medicine.

[70]  P. Allen,et al.  Binding to Ia protects an immunogenic peptide from proteolytic degradation. , 1989, Journal of immunology.

[71]  E. Unanue,et al.  Antigen presentation. , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[72]  S. Weiss,et al.  B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[73]  H. Mcconnell,et al.  Structural intermediates in the reactions of antigenic peptides with MHC molecules. , 1989, Cold Spring Harbor symposia on quantitative biology.

[74]  A. Trzeciak,et al.  A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules , 1988, Nature.

[75]  I. Berkower,et al.  Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen , 1988, The Journal of experimental medicine.

[76]  H. Bourne Do GTPases direct membrane traffic in secretion? , 1988, Cell.

[77]  J. Rothbard,et al.  Prediction and identification of an HLA‐DR‐restricted T cell determinant in the 19‐kDa protein of Mycobacteriurn tuberculosis , 1988, European journal of immunology.

[78]  R. Schwartz,et al.  Antigen-induced suppression of the proliferative response of T cell clones. , 1988, Journal of immunology.

[79]  W. Taylor,et al.  A sequence pattern common to T cell epitopes. , 1988, The EMBO journal.

[80]  J. H. Brown A hypothetical model of the foreign antigen binding site of Class II histocompatibility molecules , 1988, Nature.

[81]  J. Strominger,et al.  Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line. , 1987, The Journal of biological chemistry.

[82]  M. A. Saper,et al.  Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.

[83]  J. Strominger,et al.  Immunochemically purified DR antigens in liposomes stimulate xenogeneic cytolytic T cells in secondary in vitro cultures. , 1986, Cellular immunology.

[84]  R. Mahley,et al.  Complete protein sequence and identification of structural domains of human apolipoprotein B , 1986, Nature.

[85]  J. Silver,et al.  Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity. , 1986, Journal of immunology.

[86]  P. Cresswell Intracellular class II HLA antigens are accessible to transferrin-neuraminidase conjugates internalized by receptor-mediated endocytosis. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[87]  P. A. Peterson,et al.  Implications of the invariant gamma-chain on the intracellular transport of class II histocompatibility antigens. , 1985, Journal of immunology.

[88]  P. Parham,et al.  Exon shuffling in vivo can generate novel HLA class I molecules. , 1985, The EMBO journal.

[89]  J. Devereux,et al.  A comprehensive set of sequence analysis programs for the VAX , 1984, Nucleic Acids Res..

[90]  F T Rapaport,et al.  Appearance of cytoskeletal components on the surface of leukemia cells and of lymphocytes transformed by mitogens and Epstein-Barr virus. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[91]  J. Kaufman,et al.  Purification of HLA-linked B lymphocyte alloantigens in immunologically active form by preparative sodium dodecyl sulfate-gel electrophoresis and studies on their subunit association. , 1977, The Journal of biological chemistry.

[92]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.